Secondary Logo

Journal Logo

HIV and aging

A primer for NPs

doi: 10.1097/01.NPR.0000558144.19446.a9
CE Connection
Free

For more than 306 additional continuing education articles related to Advanced Practice Nursing topics, go to NursingCenter.com/CE.

Earn CE credit online: Go to www.nursingcenter.com/CE/NP and receive a certificate within minutes.

Notice:The Nurse Practitioner will no longer facilitate mail-in continuing-education tests, and all CE tests must be taken online at https://nursing.ceconnection.com. Please address any questions to customer service at 1-800-787-8985.

Back to Top | Article Outline

INSTRUCTIONS HIV and aging: A primer for NPs

TEST INSTRUCTIONS

  • Read the article. The test for this CE activity is to be taken online at www.nursingcenter.com/CE/NP. Tests can no longer be mailed or faxed.
  • You'll need to create (it's free!) and log in to your personal CE Planner account before taking online tests. Your planner will keep track of all your Lippincott Professional Development online CE activities for you.
  • There's only one correct answer for each question. A passing score for this test is 13 correct answers. If you pass, you can print your certificate of earned contact hours and access the answer key. If you fail, you have the option of taking the test again at no additional cost.
  • For questions, contact Lippincott Professional Development: 1-800-787-8985.
  • Registration deadline is March 5, 2021.
Back to Top | Article Outline

PROVIDER ACCREDITATION

Lippincott Professional Development will award 1.5 contact hours and 1.5 pharmacology hours for this continuing nursing education activity.

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 1.5 contact hours. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia, Georgia, and Florida, CE Broker #50-1223. Your certificate is valid in all states.

Payment: The registration fee for this test is $17.95.

HIV and aging: A primer for NPs

General Purpose: To discuss pharmacologic considerations, review common co-occurring conditions, and highlight key clinical considerations for caring for older PLWH. Learning Objectives/Outcomes: After completing this continuing-education activity, you should be able to: 1. Outline the various considerations for ART for older PLWH. 2. Describe the assessment methods useful for managing the care of older PLWH. 3. Discuss the co-occurring disorders common among older PLWH.

  1. Compared with younger PLWH and receiving ART, older PLWH receiving ART
    1. have less robust CD4+ cell recovery.
    2. take longer to achieve viral suppression.
    3. require longer, stronger courses of ART.
  2. The most common ART regimens include two NRTIs plus
    1. a PI.
    2. an INSTI.
    3. an NNRTI.
  3. Which of the following antiretroviral types has the highest likelihood of drug-drug interactions attributable to the effects of the CYP450?
    1. NRTIs
    2. INSTIs
    3. NNRTIs
  4. Which of the following antiretroviral types can interact with metformin as well as cation-containing products, such as iron and calcium?
    1. PIs
    2. INSTIs
    3. NNRTIs
  5. For patients receiving ART, HIV viral load should be checked every
    1. 1 to 2 months.
    2. 3 to 4 months.
    3. 5 to 6 months.
  6. For patients who have CD4+ cell counts between 300 and 500 cells/mcL, monitoring CD4+ cell counts is
    1. optional.
    2. essential every 6 months.
    3. generally sufficient every 12 months.
  7. A factor associated with higher rates of type 2 diabetes mellitus among PLWH is coinfection with which of the following viruses?
    1. HPV
    2. herpes zoster
    3. hepatitis C
  8. In PLWH, A1C levels for diabetes screening tend to be
    1. accurate.
    2. falsely low.
    3. falsely high.
  9. PLWH have a higher prevalence of kidney disease because of toxicity from ART, especially
    1. indinavir.
    2. rilpivirine.
    3. lamivudine.
  10. Patients who have CKD and a creatinine clearance below 50 mL/min should not take which of the following antiretroviral medications?
    1. zidovudine
    2. FTC
    3. TDF
  11. Which of the following medication classifications should be considered for patients who have CKD with proteinuria or need an antihypertensive drug?
    1. angiotensin II receptor blockers
    2. direct renin inhibitors
    3. thiazide diuretics
  12. Prevalence of which of the following types of cancer is higher among PLWH?
    1. breast
    2. prostate
    3. pharyngeal
  13. Cervical cancer screening for PLWH differs from that of people without HIV in that
    1. screening should continue at the recommended interval after age 65.
    2. the screening interval for cytology with HPV cotesting is 2 years.
    3. cytology alone without HPV cotesting is sufficient after age 60.
  14. Which of the following tools is specifically recommended as an initial screening test for HAND?
    1. Quick Neurological Screening Test
    2. MoCA
    3. Memory Impairment Screen
  15. Use of which of the following antiretroviral class of drugs increases the risks of osteopenia and osteoporosis?
    1. PIs
    2. INSTIs
    3. NNRTIs
  16. To assess mobility and physical function in older PLWH, clinicians can use the SPPB to assess balance, ability to stand from a sitting position, and
    1. pain with walking.
    2. walking duration.
    3. walking speed.
  17. According to new evidence, PLWH who have an HIV viral load of less than 200 copies/mL
    1. carry no risk of sexual transmission of HIV.
    2. have no risk of complications of HIV.
    3. no longer need ART.
  18. Currently approved for PrEP to reduce the risk of HIV infection is a tablet that combines TDF with
    1. dolutegravir.
    2. FTC.
    3. efavirenz.
Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.